Skip to content

Electrical Brain Stimulation and its benefits for Chronic Kidney Patients on Hemodialysis

Transcranial Direct Current Stimulation and its therapeutic potential in patients with Chronic Kidney Disease in Hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6fgnsqr
Enrollment
Unknown
Registered
2022-10-04
Start date
2022-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial with 5 phases: (1) initial meeting with patients to measure pain levels, mood states and functionality
(2) share of patients into two groups, each containing 15 members, being distributed according to the type of stimulation: left prefrontal dorsolateral area and sham (3) the application of ten session
E02.331.750

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 75 years; previous medical evaluation with clinical diagnosis of depression; anxiety; chronic pain and pressure lability and being on hemodialysis treatment

Exclusion criteria

Exclusion criteria: Evidence of any cognitive deficit (senile dementia, Alzheimer's); presence of physical and / or organic difficulties; individuals with severe cardiovascular risk or hemodynamically unstable; history of seizures or epileptic disease; pregnancy; metallic implants in the head or neck and cardiac pacemaker

Design outcomes

Primary

MeasureTime frame
Expected primary outcome 1: Moderate pain improvement verified by a 30% decrease in the visual analog pain scale in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS) ;Primary outcome found 1: Strong decrease in pain symptoms verified through a 79% decrease in the visual analogue pain scale in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS)

Secondary

MeasureTime frame
Expected secondary outcome 1: Depression improvement according to moderate (30% of improvement) decrease scores of the Beck depression inventory in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS);Secondary Outcome found 1: Mild decrease (13%) in the symptoms of depression verified through the decrease in the Beck Depression Inventory scores in patients undergoing hemodialysis with transcranial direct current stimulation (ETCC);Expected secondary outcome 2: Improvement of 30% or more in anxiety symptom verified by the reduction of the Hamilton Anxiety Questionnaire in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS);Secondary outcome found 2: Improvement of 23% in the symptom of anxiety verified through the decrease of the scores of the Hamilton Anxiety Questionnaire in patients who undergo hemodialysis with transcranial direct current stimulation (tDCS)

Countries

Brazil

Contacts

Public ContactRodrigo Freitas

Universidade Federal do Rio Grande do Norte

rodrigopegado@gmail.com+55(84)33422385

Outcome results

None listed

Source: REBEC (via WHO ICTRP)